BSE Live
Nov 28, 16:01Prev. Close
2235.35
Open Price
2221.00
Bid Price (Qty.)
2233.10 (49)
Offer Price (Qty.)
2682.40 (1)
NSE Live
Nov 28, 15:58Prev. Close
2230.10
Open Price
2230.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of RPG Life Sciences (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.60 | 32.29 | 2.67 | 0.51 | 8.04 | |
| Diluted EPS (Rs.) | 0.60 | 32.29 | 2.67 | 0.51 | 7.69 | |
| Cash EPS (Rs.) | 7.47 | 38.71 | 8.63 | 6.69 | 13.44 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 75.68 | 76.04 | 46.10 | 44.83 | 45.25 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 75.68 | 76.04 | 46.10 | 44.83 | 45.25 | |
| Dividend / Share(Rs.) | 0.80 | 2.00 | 1.20 | 0.80 | 1.60 | |
| Revenue from Operations/Share (Rs.) | 146.50 | 142.30 | 134.02 | 116.60 | 112.97 | |
| PBDIT/Share (Rs.) | 9.12 | 8.49 | 10.79 | 11.39 | 20.12 | |
| PBIT/Share (Rs.) | 2.25 | 2.07 | 4.82 | 5.21 | 14.36 | |
| PBT/Share (Rs.) | 0.60 | 39.29 | 0.33 | 1.05 | 10.56 | |
| Net Profit/Share (Rs.) | 0.60 | 32.29 | 2.67 | 0.51 | 7.68 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 6.22 | 5.96 | 8.05 | 9.77 | 17.80 | |
| PBIT Margin (%) | 1.53 | 1.45 | 3.60 | 4.47 | 12.71 | |
| PBT Margin (%) | 0.41 | 27.60 | 0.24 | 0.90 | 9.35 | |
| Net Profit Margin (%) | 0.41 | 22.69 | 1.98 | 0.44 | 6.80 | |
| Return on Networth / Equity (%) | 0.79 | 42.46 | 5.78 | 1.14 | 16.98 | |
| Return on Capital Employed (%) | 0.77 | 40.36 | 4.49 | 0.77 | 11.20 | |
| Return on Assets (%) | 0.50 | 27.23 | 2.14 | 0.46 | 6.71 | |
| Total Debt/Equity (X) | 0.26 | 0.11 | 0.62 | 0.61 | 0.60 | |
| Asset Turnover Ratio (%) | 123.03 | 120.02 | 107.71 | 105.42 | 98.66 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.28 | 1.32 | 0.92 | 0.97 | 0.97 | |
| Quick Ratio (X) | 0.77 | 0.73 | 0.65 | 0.57 | 0.62 | |
| Inventory Turnover Ratio (X) | 7.03 | 6.23 | 7.55 | 6.65 | 7.10 | |
| Dividend Payout Ratio (NP) (%) | 132.00 | 6.19 | 44.89 | 155.29 | 20.84 | |
| Dividend Payout Ratio (CP) (%) | 10.67 | 5.17 | 13.86 | 11.92 | 11.92 | |
| Earnings Retention Ratio (%) | -32.00 | 93.81 | 55.11 | -55.29 | 79.16 | |
| Cash Earnings Retention Ratio (%) | 89.33 | 94.83 | 86.14 | 88.08 | 88.08 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 305.59 | 112.73 | 149.36 | 150.17 | 170.10 | |
| EV/Net Operating Revenue (X) | 1.26 | 0.48 | 0.67 | 0.78 | 0.91 | |
| EV/EBITDA (X) | 20.26 | 8.03 | 8.37 | 7.97 | 5.11 | |
| MarketCap/Net Operating Revenue (X) | 1.13 | 0.42 | 0.46 | 0.55 | 0.67 | |
| Retention Ratios (%) | -32.00 | 93.80 | 55.10 | -55.29 | 79.15 | |
| Price/BV (X) | 2.19 | 0.79 | 1.35 | 1.43 | 1.68 | |
| Price/Net Operating Revenue | 1.13 | 0.42 | 0.46 | 0.55 | 0.67 | |
| Earnings Yield | 0.00 | 0.54 | 0.04 | 0.01 | 0.10 |
20.10.2025
RPG Life Standalone September 2025 Net Sales at Rs 181.68 crore, up 5.5% Y-o-Y
28.07.2025
RPG Life Standalone June 2025 Net Sales at Rs 168.92 crore, up 2.12% Y-o-Y
28.07.2025
29.04.2025
20.10.2025
RPG Life Standalone September 2025 Net Sales at Rs 181.68 crore, up 5.5% Y-o-Y
28.07.2025
RPG Life Standalone June 2025 Net Sales at Rs 168.92 crore, up 2.12% Y-o-Y
27.01.2025
RPG Life Standalone December 2024 Net Sales at Rs 172.71 crore, up 12.37% Y-o-Y
08.11.2024
RPG Life Standalone September 2024 Net Sales at Rs 172.21 crore, up 12.13% Y-o-Y